These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5540138)

  • 1. [Preparation and control of radiopharmaceuticals from generator-produced radioisotopes in medical radioisotope laboratories].
    Raban IP
    Cas Lek Cesk; 1971 Jan; 110(3):74. PubMed ID: 5540138
    [No Abstract]   [Full Text] [Related]  

  • 2. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
    Padhy AK; Dondi M
    Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear medicine affected by Energy Policy Act of 2005.
    J Nucl Med; 2005 Oct; 46(10):12N, 14N. PubMed ID: 16312055
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries.
    Perini EA; Skopchenko M; Hong TT; Harianto R; Maître A; Rodríguez MRR; de Oliveira Santos N; Guo Y; Qin X; Zeituni CA; Starovoitova VN
    Curr Radiopharm; 2019; 12(3):187-200. PubMed ID: 30924426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IAEA addresses global radioisotope shortage.
    International Atomic Energy Agency
    J Nucl Med; 2009 Jan; 50(1):15N. PubMed ID: 19139182
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
    Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ
    Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy agency examines radioisotope needs in preparation for the future.
    Tilyou SM
    J Nucl Med; 1990 Mar; 31(3):13A-19A. PubMed ID: 2307994
    [No Abstract]   [Full Text] [Related]  

  • 8. The assay in In113m in medical radioisotope laboratories.
    Husák V; Kleinbauer K
    Radiobiol Radiother (Berl); 1970; 11(3):315-22. PubMed ID: 5516526
    [No Abstract]   [Full Text] [Related]  

  • 9. A method for estimating the cost, growth rate and efficiency of radioisotope laboratories.
    Hamilton JW
    Am J Med Technol; 1968 Aug; 34(8):473-81. PubMed ID: 5674219
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
    Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding patient needs: congressmen aid nuclear medicine.
    Kotz D
    J Nucl Med; 1998 Nov; 39(11):16N, 21N-22N, 30N. PubMed ID: 9829563
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quo vadis, medicina nuclearis?].
    Rootwelt K
    Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2061-6. PubMed ID: 5479216
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guidelines for radiation protection in medicine--radiopharmaceutical quality control. German Society of Nuclear Medicine].
    Brandau W
    Nuklearmedizin; 1994 Apr; 33(2):118-24. PubMed ID: 8177754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the risk of internal contamination of workers in radioisotope laboratories in Poland].
    Adamiak-Ziemba J; Domański T; Doniec J
    Pol Tyg Lek; 1981 Aug; 36(31):1201-4. PubMed ID: 7312700
    [No Abstract]   [Full Text] [Related]  

  • 15. Government officials urge nuclear physicians to be more active in political process.
    Kotz D
    J Nucl Med; 1999 May; 40(5):13N, 15N, 31N. PubMed ID: 10319737
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of an International Atomic Energy Agency's Advisory Group meeting on "Quality control of cyclotron-produced radiopharmaceuticals".
    Vera-Ruiz H; Marcus CS; Pike VW; Coenen HH; Fowler JS; Meyer GJ; Cox PH; Vaalburg W; Cantineau R; Helus F
    Int J Rad Appl Instrum B; 1990; 17(5):445-56. PubMed ID: 2391238
    [No Abstract]   [Full Text] [Related]  

  • 17. IAEA supports training in internal dosimetry.
    Palm S
    J Nucl Med; 2010 Jul; 51(7):15N, 24N. PubMed ID: 20595506
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of generator-produced radionuclides in nuclear medicine procedures: analysis of personnel doses and laboratory work practices.
    Iyer PS; Dhond RW
    Health Phys; 1980 Sep; 39(3):576-8. PubMed ID: 7440175
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

  • 20. [Work done by the International Atomic Energy Organization in the field of nuclear medicine].
    COHEN M; DUDLEY RA; GOMEZ-CRESPO G; PEARSON JD; TSIEN KC; VETTER H
    Acta Iber Radiol Cancerol; 1962; 17():409-19. PubMed ID: 14022067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.